Understanding the epigenetic mechanisms has opened new avenues for the potential reversibility of epigenetic alterations and provided an opportunity to influence and control their unfavorable consequences. These findings not only aid in identifying novel targets for therapy but also enable the prediction of treatment response. Investigating epigenetics can uncover new targets for more effective therapeutic strategies and identify novel biomarkers for diagnosing HCC in the future.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Download PDF 
Post
